Navigation Links
Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management

RESEARCH TRIANGLE PARK, N.C., July 8 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) today announced that Lafmin Morgan has joined the Global Commercial Operations team as vice president, U.S. Product Management.  In this role, Morgan will be responsible for product management and marketing of the company's full product portfolio in the U.S.

"Lafmin brings significant experience and leadership to Talecris and will strengthen our capabilities as we pursue the continued growth of Talecris' U.S. business," said John Perkins, executive vice president, Global Commercial Operations.

Morgan joins Talecris from GlaxoSmithKline (GSK), where he served for more than twenty years in finance, sales, commercial strategy and marketing roles across multiple therapeutic areas. His most recent role at GSK was vice president, Commercial Model Innovations, in which he led GSK's effort to build a new sales and marketing model for the company's entire U.S. business.

Prior to that, Morgan served at GSK as vice president of Sales, a position in which he managed a 2000-person sales force and served as chair of the U.S. Sales Leadership Team. He also served as vice president of Respiratory Marketing, where he implemented a marketing strategy that grew the $5 billion respiratory portfolio by 13 percent in just over one year.  

Morgan holds a Bachelor of Science in Business Administration and a Master of Business Administration from the University of North Carolina at Chapel Hill.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit:

SOURCE Talecris Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
2. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
3. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York
5. Amylin Pharmaceuticals to Present at Thomas Weisel Healthcare, BioCentury NewsMakers, and Morgan Stanley Global Healthcare Conferences
6. NeurogesX to Present at Morgan Stanley Global Healthcare Unplugged Conference
7. NuVasive to Present at Morgan Stanley Global Healthcare Unplugged Conference
8. BioMarin to Present at the Morgan Stanley Global Healthcare Conference
9. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
10. Hologic to Present at the Morgan Stanley Global Healthcare Unplugged Conference
11. Pharmasset to Present at the Upcoming Citibank and Morgan Stanley Investor Conferences
Post Your Comments:
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced the ... NIH to develop RealSeq®-SC (Single Cell), expected to be ... small RNAs (including microRNAs) from single cells using NGS ... the need to accelerate development of approaches to analyze ... "New techniques for measuring levels of mRNAs ...
(Date:10/9/2017)... ... ... The award-winning American Farmer television series will feature 3 Bar Biologics in ... 8:30aET on RFD-TV. , With global population estimates nearing ten billion people by ... feed a growing nation. At the same time, many of our valuable resources are ...
(Date:10/7/2017)... , ... October 06, 2017 ... ... experience providing advanced instruments and applications consulting for microscopy and surface analysis, ... in application consulting, Nanoscience Analytical offers a broad range of contract analysis ...
Breaking Biology Technology:
(Date:4/17/2017)... MELBOURNE, Florida , April 17, 2017 ... security technology company, announces the filing of its 2016 Annual Report ... Securities and Exchange Commission. ... Report on Form 10-K is available in the Investor Relations section ... well as on the SEC,s website at . ...
(Date:4/11/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 30.37% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
Breaking Biology News(10 mins):